EFM
E Fund Management’s ImmunityBio IBRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $74.2K | Sell |
28,108
-2,223
| -7% | -$5.87K | ﹤0.01% | 380 |
|
|
2025
Q1 | $91.3K | Sell |
30,331
-8,569
| -22% | -$25.8K | ﹤0.01% | 386 |
|
|
2024
Q4 | $99.6K | Buy |
38,900
+9,622
| +33% | +$24.6K | 0.01% | 378 |
|
|
2024
Q3 | $109K | Buy |
29,278
+2,820
| +11% | +$10.5K | 0.01% | 339 |
|
|
2024
Q2 | $167K | Sell |
26,458
-35,464
| -57% | -$224K | 0.01% | 300 |
|
|
2024
Q1 | $333K | Buy |
61,922
+22,428
| +57% | +$120K | 0.02% | 263 |
|
|
2023
Q4 | $198K | Buy |
+39,494
| New | +$198K | 0.01% | 286 |
|
|
2023
Q1 | – | Sell |
-24,706
| Closed | -$125K | – | 344 |
|
|
2022
Q4 | $125K | Sell |
24,706
-3,098
| -11% | -$15.7K | 0.01% | 321 |
|
|
2022
Q3 | $138K | Buy |
+27,804
| New | +$138K | 0.01% | 320 |
|
|
2022
Q2 | – | Sell |
-22,816
| Closed | -$128K | – | 336 |
|
|
2022
Q1 | $128K | Buy |
22,816
+7,933
| +53% | +$44.5K | ﹤0.01% | 312 |
|
|
2021
Q4 | $90K | Buy |
14,883
+2,245
| +18% | +$13.6K | ﹤0.01% | 289 |
|
|
2021
Q3 | $123K | Buy |
+12,638
| New | +$123K | 0.01% | 254 |
|